Last updated: November 23, 2022
Sponsor: Eye & ENT Hospital of Fudan University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Nasopharyngeal Cancer
Carcinoma
Treatment
N/AClinical Study ID
NCT05627310
AIAD202204
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- The quality of endoscopic images should clinical acceptable.
- Patients were diagnosed with biopsy(NPC, benign hyperplasia). Control corhort(normalnasopharynx) don't require bispsy result.
Exclusion
Exclusion Criteria:
- images with spots from lens flares or stains, and overexposure were excluded fromfurther analysis.
- image can not expose most part of lesion clearly.
Study Design
Total Participants: 50000
Study Start date:
November 01, 2022
Estimated Completion Date:
March 31, 2024
Study Description
Connect with a study center
Fujian Medical University Union Hospital
Fuzhou, Fujian
ChinaActive - Recruiting
Quan Zhou First Affiliated Hospital of Fujian Medical University
Quanzhou, Fujian
ChinaActive - Recruiting
The People' s Hospital of Jiangmen
Jiangmen, Guangdong
ChinaActive - Recruiting
First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi
ChinaActive - Recruiting
The People' s Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi
ChinaActive - Recruiting
Xiangya Hospital of Central South University
Changsha, Hunan
ChinaActive - Recruiting
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi
ChinaActive - Recruiting
Eye&ENT Hospital of Fudan University
Shanghai, Shanghai
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.